Patents by Inventor Aaron Mathias

Aaron Mathias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES
    Publication number: 20240180859
    Abstract: The present invention relates to compositions comprising resolvins and their use in methods of treating immune-mediated inflammatory disease.
    Type: Application
    Filed: October 25, 2023
    Publication date: June 6, 2024
    Applicant: Thetis Pharmaceuticals LLC
    Inventors: Gary Mathias, John Parkinson, Aaron Mathias, Frank C. Sciavolino
  • Compositions and methods for cancer therapy
    Patent number: 11986512
    Abstract: The present invention relates to compositions comprising resolvins and their use in methods of treating cancer.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: May 21, 2024
    Inventors: Gary Mathias, Dipak Panigrahy, John Parkinson, Aaron Mathias, Frank C. Sciavolino
  • COMPOSITIONS AND METHODS FOR CANCER THERAPY
    Publication number: 20240156909
    Abstract: The present invention relates to compositions comprising resolvins and their use in methods of treating cancer.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicants: Thetis Pharmaceuticals LLC, Beth Israel Deaconess Medical Center
    Inventors: Gary Mathias, Dipak Panigraphy, John Parkinson, Aaron Mathias, Frank C. Sciavolino
  • COMPOSITIONS AND METHODS FOR CANCER THERAPY
    Publication number: 20230133085
    Abstract: The present invention relates to compositions comprising resolvins and their use in methods of treating cancer.
    Type: Application
    Filed: October 26, 2022
    Publication date: May 4, 2023
    Applicants: Thetis Pharmaceuticals LLC, Beth Israel Deaconess Medical Center
    Inventors: Gary Mathias, Dipak Panigrahy, John Parkinson, Aaron Mathias, Frank C. Sciavolino